Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74(5) of SEBI DP Regulation for the quarter ended on 30th June, 2024.
15-07-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window

Closure of Trading Window
30-06-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement Under Regulation 30 (LODR) (Clarification Letter For Error In Standalone Result Filled For The Quarter And Half Year Ended September 30, 2023)

Clarification regarding error in standalone financial results for the quarter and half year ended 30th September, 2023.
21-06-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report of the company for the period ended on 31st march, 2024.
21-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report of the company for the period ended on 31st march, 2024.
21-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Revised Financial Results For The Period Of March 31, 2024

We are submitting the Revised Financial Results; The statement of Standalone Audited Financial Results of the Company for the period of March 31, 2024.
17-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Publication of Audited Financial Results for the Quarter and Year ended on 31st March, 2024.
03-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Results-Financial Results For March 31, 2024

Audited Financial Results for the year ended on 31st March, 2024.
02-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2024.

With reference to above, we hereby inform that meeting of Board of Directors of the Company held today (i.e., 02/05/2024), in which Board has approved and adopted the standalone Audited Financial Results of the Company for the Quarter and year ended 31st March, 2024. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2024. 2. Auditors'' Report on Standalone Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com
02-05-2024
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Considering And Approving The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024.

Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024.
25-04-2024
Next Page
Close

Let's Open Free Demat Account